Teligent Retained Earnings (Accumulated Deficit) 2010-2021 | TLGT
Teligent retained earnings (accumulated deficit) from 2010 to 2021. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Teligent Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2020 |
$-243 |
| 2019 |
$-121 |
| 2018 |
$-96 |
| 2017 |
$-60 |
| 2016 |
$-45 |
| 2015 |
$-33 |
| 2014 |
$-40 |
| 2013 |
$-45 |
| 2012 |
$-43 |
| 2011 |
$-40 |
| 2010 |
$-37 |
| 2009 |
$-32 |
Teligent Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2021-06-30 |
$-254 |
| 2021-03-31 |
$-241 |
| 2020-12-31 |
$-243 |
| 2020-09-30 |
$-163 |
| 2020-06-30 |
$-163 |
| 2020-03-31 |
$-148 |
| 2019-12-31 |
$-121 |
| 2019-09-30 |
$-116 |
| 2019-06-30 |
$-109 |
| 2019-03-31 |
$-105 |
| 2018-12-31 |
$-96 |
| 2018-09-30 |
$-82 |
| 2018-06-30 |
$-78 |
| 2018-03-31 |
$-65 |
| 2017-12-31 |
$-60 |
| 2017-09-30 |
$-54 |
| 2017-06-30 |
$-45 |
| 2017-03-31 |
$-44 |
| 2016-12-31 |
$-45 |
| 2016-09-30 |
$-39 |
| 2016-06-30 |
$-37 |
| 2016-03-31 |
$-34 |
| 2015-12-31 |
$-33 |
| 2015-09-30 |
$-27 |
| 2015-06-30 |
$-24 |
| 2015-03-31 |
$-33 |
| 2014-12-31 |
$-40 |
| 2014-09-30 |
$-45 |
| 2014-06-30 |
$-45 |
| 2014-03-31 |
$-45 |
| 2013-12-31 |
$-45 |
| 2013-09-30 |
$-44 |
| 2013-06-30 |
$-44 |
| 2013-03-31 |
$-44 |
| 2012-12-31 |
$-43 |
| 2012-09-30 |
$-42 |
| 2012-06-30 |
$-41 |
| 2012-03-31 |
$-40 |
| 2011-12-31 |
$-40 |
| 2011-09-30 |
$-39 |
| 2011-06-30 |
$-38 |
| 2011-03-31 |
$-38 |
| 2010-12-31 |
$-37 |
| 2010-09-30 |
$-36 |
| 2010-06-30 |
$-34 |
| 2010-03-31 |
$-33 |
| 2009-12-31 |
$-32 |
| 2009-09-30 |
$-31 |
| 2009-06-30 |
$-30 |
| 2009-03-31 |
$-26 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
